VANCOUVER, Nov. 13, 2019 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN; FWB: 1UB; OTCQB: CGNSF) today announced the…
Read More
VANCOUVER, Oct. 29, 2019 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN; FWB: 1UB; OTCQB: CGNSF) today confirmed that…
Innovate UK awards prestigious CA $1.3 million grant to Cognetivity to develop early dementia detection technology in UK National Health Service Cognetivity…
Tom Sawyer, Chief Operating Officer of Cognetivity told The Sociable that their test could be saving time and money by catching…
Cognetivity Neurosciences announces significant expansion of its UK NHS based clinical trial centers
VANCOUVER, Oct. 10, 2019 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN; FWB: 1UB; OTCQB: CGNSF) has confirmed positive…
VANCOUVER, Sept. 12, 2019 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN; FWB:1UB; OTCQB: CGNSF) announced that results from its research…
VANCOUVER, Sept. 10, 2019 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN; FWB:1UB; OTCQB: CGNSF) today announced that its technology…
The total number of people with dementia in China projected to reach 14.1 million by 2020 and 23.3 million by 2030. Annual…
Listen to doctor Thomas Sawyer, COO @ Cognetivity talk about an innovative digital platform platform (leveraging image recognition and Artificial…
Quatz’s health and science reporter takes a look at how visual tests may be the key to detecting dementia
